5-HT4 RECEPTOR AGONIST COMPOUNDS
1 Assignment
0 Petitions
Accused Products
Abstract
The invention provides novel quinolinone-carboxamide 5-HT4 receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
-
Citations
36 Claims
-
1-20. -20. (canceled)
- 21. A pharmaceutical composition comprising a pharmaceutically-acceptable carrier and a compound of formula (I):
Specification